v3.26.1
BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Schedule of Research and Development Expense [Line Items]        
Research and development $ 2,959 $ 2,580 $ 5,608 $ 4,837
Research        
Schedule of Research and Development Expense [Line Items]        
Research and development 274 291 567 605
Drug Development        
Schedule of Research and Development Expense [Line Items]        
Research and development 1,106 1,095 2,234 2,176
Other        
Schedule of Research and Development Expense [Line Items]        
Research and development $ 1,579 $ 1,195 $ 2,808 $ 2,057